株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アジア太平洋地域における遺伝子検査市場の見通し

Asia-Pacific Genetic Testing Market Outlook to 2024

発行 GlobalData 商品コード 348478
出版日 ページ情報 英文 85 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
アジア太平洋地域における遺伝子検査市場の見通し Asia-Pacific Genetic Testing Market Outlook to 2024
出版日: 2017年12月01日 ページ情報: 英文 85 Pages
概要

当レポートでは、アジア太平洋地域における遺伝子検査市場について調査分析し、セグメント別の収益実績・予測、カテゴリー別の企業シェア・流通シェア、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 アジア太平洋地域における遺伝子検査市場

  • 収益
  • カテゴリー比較:収益別
  • 収益実績
  • 収益予測
  • 企業シェア:収益別

第4章 オーストラリアの遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第5章 中国の遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第6章 インドの遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第7章 日本の遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第8章 韓国の遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第9章 アジア太平洋地域における遺伝子検査市場の主要企業の概要

  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Siemens Healthcare
  • Transgenomic, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux S.A.

第10章 遺伝子検査市場パイプライン製品

第11章 最近の発展

  • 企業広報
  • 決算発表
  • 法規制
  • その他の重要な発展
  • 戦略と事業計画

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECR0760DB

GlobalData's new report, Asia-Pacific Genetic Testing Market Outlook to 2024, provides key market data on the Asia-Pacific Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 What Is This Report About? 6
  • 2.2 Genetic Testing Market Segmentation 6
  • 2.3 Definitions of Markets Covered in the Report 7

3 Genetic Testing Market, Asia-Pacific 8

  • 3.1 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2024 8
  • 3.2 Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), 2010-2024 10
  • 3.3 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2017 12
  • 3.4 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2017-2024 14
  • 3.5 Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), 2017 16

4 Genetic Testing Market, Australia 18

  • 4.1 Genetic Testing Market, Australia, Revenue ($m), 2010-2017 18
  • 4.2 Genetic Testing Market, Australia, Revenue ($m), 2017-2024 20
  • 4.3 Genetic Testing Market, Australia, Distribution Share by Revenue ($m), 2017 22
  • 4.4 Genetic Testing Market, Australia, Company Share by Revenue ($m), 2017 23

5 Genetic Testing Market, China 25

  • 5.1 Genetic Testing Market, China, Revenue ($m), 2010-2017 25
  • 5.2 Genetic Testing Market, China, Revenue ($m), 2017-2024 27
  • 5.3 Genetic Testing Market, China, Distribution Share by Revenue ($m), 2017 29
  • 5.4 Genetic Testing Market, China, Company Share by Revenue ($m), 2017 30

6 Genetic Testing Market, India 32

  • 6.1 Genetic Testing Market, India, Revenue ($m), 2010-2017 32
  • 6.2 Genetic Testing Market, India, Revenue ($m), 2017-2024 34
  • 6.3 Genetic Testing Market, India, Distribution Share by Revenue ($m), 2017 36
  • 6.4 Genetic Testing Market, India, Company Share by Revenue ($m), 2017 37

7 Genetic Testing Market, Japan 39

  • 7.1 Genetic Testing Market, Japan, Revenue ($m), 2010-2017 39
  • 7.2 Genetic Testing Market, Japan, Revenue ($m), 2017-2024 41
  • 7.3 Genetic Testing Market, Japan, Distribution Share by Revenue ($m), 2017 43
  • 7.4 Genetic Testing Market, Japan, Company Share by Revenue ($m), 2017 44

8 Genetic Testing Market, South Korea 46

  • 8.1 Genetic Testing Market, South Korea, Revenue ($m), 2010-2017 46
  • 8.2 Genetic Testing Market, South Korea, Revenue ($m), 2017-2024 48
  • 8.3 Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), 2017 50
  • 8.4 Genetic Testing Market, South Korea, Company Share by Revenue ($m), 2017 51

9 Overview of Key Companies in Asia-Pacific Genetic Testing Market 53

  • 9.1 F. Hoffmann-La Roche Ltd 53
    • 9.1.1 Company Overview 53
  • 9.2 PerkinElmer Inc 53
    • 9.2.1 Company Overview 53
  • 9.3 Abbott Laboratories 53
    • 9.3.1 Company Overview 53
  • 9.4 Qiagen NV 54
    • 9.4.1 Company Overview 54
  • 9.5 Hologic Inc 54
    • 9.5.1 Company Overview 54

10 Genetic Testing Market Pipeline Products 55

11 Recent Developments 58

  • 11.1 Corporate Communications 58
    • 11.1.1 Oct 29, 2017: George Church, a world-renowned scientist, joins the scientific advisory board of CloudHealth Medical Group to advise on the strategic development of their "pan-omics" direct to consumer platform 58
    • 11.1.2 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 58
    • 11.1.3 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 59
    • 11.1.4 Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 59
  • 11.2 Financial Announcements 60
    • 11.2.1 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 60
    • 11.2.2 Jul 27, 2017: Genetic Technologies: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017 61
    • 11.2.3 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 63
    • 11.2.4 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 64
    • 11.2.5 Jan 31, 2017: Vela Diagnostics, a turnkey manufacturer for IVD NGS and PCR workflow solutions announces its 2016 results and highlights 65
    • 11.2.6 Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update 66
  • 11.3 Legal And Regulatory 66
    • 11.3.1 Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 66
  • 11.4 Other Significant Developments 67
    • 11.4.1 Oct 30, 2017: Genetic Technologies Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017 67
    • 11.4.2 Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 69
    • 11.4.3 Sep 25, 2017: Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific 70
    • 11.4.4 Aug 25, 2017: Genetic Technologies Announces Comprehensive Review of Strategic Alternatives 70
    • 11.4.5 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 71
    • 11.4.6 Aug 16, 2017: FDA Accepts Supplemental Biologics License Application and Grants Priority Review for ADCETRIS (Brentuximab Vedotin) in Cutaneous T-Cell Lymphoma 71
    • 11.4.7 Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000 73
    • 11.4.8 Mar 07, 2017: Vela Genomics Launches NGS Clinical Interpretation and Reporting 73
    • 11.4.9 Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 73
    • 11.4.10 Jan 04, 2017: GrandOmics Biosciences Expands Investment in PacBio's Sequel Systems for Precision Medicine Initiative 74
  • 11.5 Product News 75
    • 11.5.1 Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation 75
    • 11.5.2 Jun 02, 2017: Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary 75
    • 11.5.3 Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 76
    • 11.5.4 Mar 09, 2017: New test to monitor the success of bone marrow transplants 77
    • 11.5.5 Feb 23, 2017: CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq Panel for both Cancer and Non-Cancer Immunotherapies 77

12 Appendix 79

  • 12.1 Research Methodology 80
    • 12.1.1 Coverage 80
    • 12.1.2 Secondary Research 80
    • 12.1.3 Primary Research 81
    • 12.1.4 Market Modeling and Forecasting 82
    • 12.1.5 Company Share Analysis 83
    • 12.1.6 Distribution Share Analysis 84
    • 12.1.7 Benchmarking 84
  • 12.2 GlobalData Consulting 84
  • 12.3 Contact Us 85
  • 12.4 Disclaimer 85

List of Tables

1.1 List of Tables

  • Table 1: Genetic Testing Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2010-2024 9
  • Table 2: Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2010-2024 11
  • Table 3: Genetic Testing Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2010-2017 13
  • Table 4: Genetic Testing Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2017-2024 15
  • Table 5: Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2017 17
  • Table 6: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 19
  • Table 7: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 21
  • Table 8: Genetic Testing Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 22
  • Table 9: Genetic Testing Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 24
  • Table 10: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 26
  • Table 11: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 28
  • Table 12: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 29
  • Table 13: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2017 31
  • Table 14: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 33
  • Table 15: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 35
  • Table 16: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 36
  • Table 17: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2017 38
  • Table 18: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 40
  • Table 19: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 42
  • Table 20: Genetic Testing Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 43
  • Table 21: Genetic Testing Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 45
  • Table 22: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 47
  • Table 23: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 49
  • Table 24: Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 50
  • Table 25: Genetic Testing Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 52
  • Table 26: Genetic Testing Market Pipeline Products 55
  • Table 27: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 82

List of Figures

1.2 List of Figures

  • Figure 1: Genetic Testing Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2010-2024 8
  • Figure 2: Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2010-2024 10
  • Figure 3: Genetic Testing Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2010-2017 12
  • Figure 4: Genetic Testing Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2017-2024 14
  • Figure 5: Genetic Testing Market, Asia-Pacific, Company Share (%) 2017 16
  • Figure 6: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 18
  • Figure 7: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 20
  • Figure 8: Genetic Testing Market, Australia, Company Share (%) 2017 23
  • Figure 9: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 25
  • Figure 10: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 27
  • Figure 11: Genetic Testing Market, China, Company Share (%) 2017 30
  • Figure 12: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 32
  • Figure 13: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 34
  • Figure 14: Genetic Testing Market, India, Company Share (%) 2017 37
  • Figure 15: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 39
  • Figure 16: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 41
  • Figure 17: Genetic Testing Market, Japan, Company Share (%) 2017 44
  • Figure 18: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 46
  • Figure 19: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 48
  • Figure 20: Genetic Testing Market, South Korea, Company Share (%) 2017 51
Back to Top